524768 EMMESSA

Emmessar Biotech & Nutrition Share Price

 

 

Start SIP in EMMESSA

Start SIP

Performance

  • Low
  • ₹26
  • High
  • ₹27
  • 52 Week Low
  • ₹24
  • 52 Week High
  • ₹43
  • Open Price₹27
  • Previous Close₹27
  • Volume997
  • 50 DMA₹28.20
  • 100 DMA₹29.29
  • 200 DMA₹31.02

Investment Returns

  • Over 1 Month -8.56%
  • Over 3 Month -14.5%
  • Over 6 Month -6.26%
  • Over 1 Year -22.65%

Smart Investing Starts Here Start SIP with Emmessar Biotech & Nutrition for Steady Growth!

Invest Now

Emmessar Biotech & Nutrition Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 39.1
  • PEG Ratio
  • -0.7
  • Market Cap Cr
  • 13
  • P/B Ratio
  • 1.6
  • Average True Range
  • 2.28
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.46
  • RSI
  • 42.19
  • MFI
  • 44.93

Emmessar Biotech & Nutrition Financials

Emmessar Biotech & Nutrition Technicals

EMA & SMA

Current Price
₹26.06
-1.34 (-4.89%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹27.26
  • 50 Day
  • ₹28.20
  • 100 Day
  • ₹29.29
  • 200 Day
  • ₹31.02

Resistance and Support

26.33 Pivot Speed
  • R3 29.06
  • R2 28.23
  • R1 27.16
  • S1 25.26
  • S2 24.43
  • S3 23.36

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Emmessar Biot.& Nut. has an operating revenue of Rs. 0.37 Cr. on a trailing 12-month basis. An annual revenue growth of 3% is not great, Pre-tax margin of 157% is great, ROE of 4% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 45 which is a POOR score indicating inconsistency in earnings, a RS Rating of 43 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 96 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Emmessar Biotech & Nutrition Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-11 Quarterly Results
2025-11-12 Quarterly Results
2025-08-07 Quarterly Results
2025-04-24 Audited Results
2025-02-06 Quarterly Results

Emmessar Biotech & Nutrition F&O

Emmessar Biotech & Nutrition Shareholding Pattern

59.53%
0.05%
0.14%
38.09%
2.19%

About Emmessar Biotech & Nutrition

  • NSE Symbol
  • EMMESSA
  • BSE Symbol
  • 524768
  • Managing Director
  • Mr. Srinivasa Raghavan Mathurakavi Ayyangar
  • ISIN
  • INE634B01016

Similar Stocks to Emmessar Biotech & Nutrition

Emmessar Biotech & Nutrition FAQs

Emmessar Biotech & Nutrition share price is ₹26 As on 17 February, 2026 | 18:02

The Market Cap of Emmessar Biotech & Nutrition is ₹13 Cr As on 17 February, 2026 | 18:02

The P/E ratio of Emmessar Biotech & Nutrition is 39.1 As on 17 February, 2026 | 18:02

The PB ratio of Emmessar Biotech & Nutrition is 1.6 As on 17 February, 2026 | 18:02

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23